Provided by Tiger Trade Technology Pte. Ltd.

Onconetix Inc.

0.6268
+0.01452.37%
Pre-market: 0.65550.0287+4.58%06:09 EDT
Volume:153.66K
Turnover:94.76K
Market Cap:2.48M
PE:-0.23
High:0.6400
Open:0.6000
Low:0.5868
Close:0.6123
52wk High:209.50
52wk Low:0.5868
Shares:3.95M
Float Shares:3.69M
Volume Ratio:1.05
T/O Rate:4.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.6880
EPS(LYR):-828.1488
ROE:-105.23%
ROA:-27.03%
PB:0.18
PE(LYR):0.00

Loading ...

Onconetix Inc trading halted, news pending

TIPRANKS
·
May 21

BUZZ-U.S. STOCKS ON THE MOVE-T1 Energy, Home Depot, X-Energy

Reuters
·
May 19

BRIEF-Onconetix, Inc. Announces 1-For-10 Reverse Stock Split

Reuters
·
May 19

BRIEF-Realbotix Provides Update On Nasdaq Listing

Reuters
·
May 19

Onconetix, Inc. Announces 1-for-10 Reverse Stock Split

THOMSON REUTERS
·
May 19

Realbotix says Nasdaq reverse takeover listing for unit expected to close by October 2026

Reuters
·
May 19

Realbotix Corp - to Retain 75–90% Ownership of Realllc After Nasdaq Listing

THOMSON REUTERS
·
May 19

Onconetix (ONCO) Stock Surges Over 23% Overnight: Why Is It Moving?

Benzinga Earnings
·
May 19

Onconetix Q1 EPS $(6.71) Up From $(225.25) YoY, Sales $21.457K Down From $101.630K YoY

Benzinga Earnings
·
May 13

Onconetix unit Proteomedix launches Proclarix U.S. validation study with Labcorp

Reuters
·
May 13

Onconetix Q1 net loss narrows 50.7% to $4.21 million

Reuters
·
May 13

Oncopeptides showcases new Pepaxti data to bolster multiple myeloma positioning

TIPRANKS
·
May 13

Oncopeptides posts strong Q1 sales growth as Pepaxti momentum builds in Europe

TIPRANKS
·
May 13

Onconetix:Prospectus Relates to Offer & Sale From Time to Time by Keystone Capital Partners of up to 25 Mln Shares of Common Stock of Co

THOMSON REUTERS
·
May 12

Oncopeptides Targets Third-Line Multiple Myeloma Indication to Boost Pepaxti Growth

TIPRANKS
·
May 11

Oncopeptides Sets May 13 Webcast for Q1 2026 Results

TIPRANKS
·
May 06

Onconetix files to sell 25M shares of common stock for holders

TIPRANKS
·
Apr 29

Oncopeptides Marks Growth Phase as 2025 Annual Report Highlights Pepaxti Momentum

TIPRANKS
·
Apr 29

BRIEF-Onconetix Inc Andrew Oakley Resigns As Chairman Of Board

Reuters
·
Apr 25

Onconetix Inc - Appoints Sammy Dorf as Chairman of the Board Effective April 23, 2026 - SEC Filing

THOMSON REUTERS
·
Apr 25